Paraxanthine: What It Is and How It Works
Paraxanthine is one of the most discussed "new" sports nutrition substances, even though every coffee lover gets it every day. The editorial team explains what this molecule is, how it forms in the body, how it works, and how it differs from caffeine.
What paraxanthine is
Paraxanthine (1,7-dimethylxanthine) is a methylxanthine, a close relative of caffeine, theobromine and theophylline. The most interesting thing about it is that everyone who drinks coffee is already getting paraxanthine: it is into this substance that the liver converts most of the caffeine consumed.
Chemically, the difference between caffeine and paraxanthine is one methyl group. Caffeine has three methyl groups (1,3,7-trimethylxanthine), while paraxanthine has two, at positions 1 and 7. It might seem like a trifle, but it is precisely this that determines how the molecule interacts with enzymes and receptors.
As a standalone dietary supplement ingredient, paraxanthine appeared relatively recently — in the early 2020s, when its industrial production was successfully established. Before that it was known mainly to pharmacologists as the principal metabolite of caffeine, whose concentration is used, in particular, to assess the activity of the liver enzyme CYP1A2.
The manufacturers' idea is simple: if a significant part of coffee's effects is actually linked to paraxanthine, then one can take the "active part" itself, bypassing the other metabolites. How justified this logic is, the editorial team examines below.
How paraxanthine forms in the body
After coffee is consumed, caffeine is almost completely absorbed in the intestine and reaches the liver. There the cytochrome P450 1A2 enzyme (CYP1A2) removes one methyl group from the molecule. Depending on which one, paraxanthine, theobromine or theophylline is formed. The main pathway is the paraxanthine one.
Next, paraxanthine itself undergoes further metabolism and is excreted in urine as a series of products. In humans the half-life of paraxanthine is generally comparable to that of caffeine and amounts to several hours, although the exact figures depend substantially on CYP1A2 activity.
The activity of this enzyme is highly individual. As shown in the review by Nehlig, it is increased by smoking and altered by genetic variants, pregnancy, oral contraceptives, some medications and liver diseases. Because of this, in some people coffee "wears off" within a few hours, while in others it lasts until night.
Taking ready-made paraxanthine partly bypasses the first stage of this chain. A person gets a molecule that does not need demethylation, and therefore, according to the manufacturers' hypothesis, the effect depends less on CYP1A2 genetics, although the subsequent elimination of paraxanthine still goes through liver enzymes.
Mechanism of action
The main mechanism of action of paraxanthine, as with caffeine, is blockade of adenosine A1 and A2A receptors. Adenosine accumulates in the brain during the day and signals fatigue. When a methylxanthine occupies its receptors, the "time to rest" signal weakens and neuronal activity increases.
The study by Orrú and colleagues (2013) showed an interesting feature: in rats paraxanthine produced a pronounced psychostimulant effect and also enhanced dopamine release in the striatum. The authors linked this to inhibition of phosphodiesterase and the nitric oxide signaling pathway — a mechanism that is not present in this form in caffeine.
In the same work, paraxanthine, unlike caffeine, did not increase anxiety-like behavior in the animals. It is precisely this finding that became the basis for the marketing thesis of "stimulation without anxiety." However, one must remember: this concerns data in rodents, and transferring it to humans requires confirmation.
The cardiovascular effects of paraxanthine in humans were studied back in the 1990s. Benowitz and colleagues showed that paraxanthine, like caffeine, raises blood pressure and the level of adrenaline in the blood, that is, it is not devoid of sympathomimetic action. This is an important counterargument to advertising about an "absolutely mild" stimulant.
| Characteristic | Caffeine | Paraxanthine |
|---|---|---|
| Chemical name | 1,3,7-trimethylxanthine | 1,7-dimethylxanthine |
| Origin in supplements | Natural or synthetic | Synthetic (naturally — a metabolite of caffeine) |
| Need for CYP1A2 to activate | Metabolized into active products | Already the "final" active molecule of the first stage |
| Blockade of adenosine receptors | Yes | Yes |
| Effect on blood pressure and adrenaline | Yes | Yes (Benowitz, 1995) |
| Volume of human studies | Very large | Limited |
Potential benefits
What might make paraxanthine interesting to an athlete or a person doing mental work? First — a more stable response. If the effect of coffee strongly depends on individual metabolism, then taking the metabolite theoretically gives a more predictable result.
Second — the side-effect profile. Among the metabolites of caffeine, theophylline and theobromine have their own effects, in particular on the smooth muscle of the bronchi and the heart. Taking "pure" paraxanthine excludes them, although how clinically significant this is at usual doses is unknown.
Third — cognitive action. A randomized crossover study by Xing and colleagues (2021) evaluated different doses of paraxanthine and found improvement in certain measures of memory, attention and reaction speed compared to placebo. This is one of the few direct pieces of data in humans.
Fourth — a potential effect on muscles. A study by Jäger and colleagues in mice showed an increase in muscle mass, strength and endurance with paraxanthine intake. But this is an animal model, and any conclusions for humans are still premature. More detail on the evidence base is in a separate material.
Limitations and status
Despite the interesting mechanisms, paraxanthine remains a poorly studied substance. The number of randomized controlled trials in humans can be counted in single digits, and a significant portion of them were funded by manufacturers. This does not make the results false, but it calls for caution in interpretation.
The long-term safety of regular paraxanthine intake as a standalone supplement has not been studied the way the safety of coffee has. It is logical to assume that at moderate doses the risks are similar to those of caffeine, since paraxanthine forms in the body of everyone who drinks coffee anyway. But "logical to assume" is not the same as "proven."
As for sports status: caffeine and its metabolites are not on the WADA Prohibited List, and caffeine is included in the monitoring program. Paraxanthine is not a prohibited substance, but athletes should keep an eye on updates to their federation's rules.
Let us summarize the key facts about paraxanthine:
- it is the principal metabolite of caffeine in the human body;
- it acts through blockade of adenosine receptors and, according to animal data, through dopamine mechanisms;
- it is not devoid of effects on blood pressure and the sympathetic nervous system;
- it has a limited but encouraging evidence base regarding cognitive function.
These facts are enough to take an interest in the substance, but not enough to consider it "better than caffeine" for everyone.
Editorial conclusions
Paraxanthine is not an exotic substance but the main product of caffeine's transformation in the human liver. Taking it as a supplement is an attempt to get the "active part" of coffee directly.
Its mechanism of action is similar to caffeine, but, according to animal studies, it has features related to dopamine and lower anxiety. In humans paraxanthine, like caffeine, raises blood pressure and adrenaline levels.
The evidence base in humans is still small, so loud promises should be treated critically and the substance taken with the same caution as caffeine.
Our articles "Benefits of Paraxanthine for Athletes: The Evidence Base," "Side Effects of Paraxanthine" and "How to Take Paraxanthine" will help continue the topic.
References
- Arnaud MJ. Pharmacokinetics and metabolism of natural methylxanthines in animal and man. Handb Exp Pharmacol. 2011;(200):33–91.
- Orrú M, Guitart X, Karcz-Kubicha M, et al. Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans. Neuropharmacology. 2013;67:476–484.
- Benowitz NL, Jacob P 3rd, Mayan H, Denaro C. Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther. 1995;58(6):684–691.
- Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018;70(2):384–411.
- Xing D, Yoo C, Gonzalez D, et al. Dose-response of paraxanthine on cognitive function: a double blind, placebo controlled, crossover trial. Nutrients. 2021;13(12):4478.
- Jäger R, Purpura M, Wells SD, Liao K, Godavarthi A. Paraxanthine supplementation increases muscle mass, strength, and endurance in mice. Nutrients. 2022;14(4):893.
- Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83–133.
- World Anti-Doping Agency. The 2025 Monitoring Program. Montreal: WADA; 2025.
Andriy Melnyk
A strength-sports coach and author of programs for beginner and intermediate levels. Writes about training planning.
